Hahaha.
And what would be your take on the same former employee telling another well known finance journalist in an interview that the DEP-Docetaxel trial would complete and results announced by end of 2018, only for it to painstakingly drag on for another 5 years?
It would be understandable if some shareholders have felt misled over the journey by some of the statements out of HQ such as this and many others.
Could this happen to Viraleze with marketing approval, page-28
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add SPL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
9.9¢ |
Change
-0.006(5.71%) |
Mkt cap ! $41.39M | |||
| Open | High | Low | Value | Volume |
| 10.5¢ | 10.5¢ | 9.9¢ | $23.28K | 232.2K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 25000 | 9.9¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 10.5¢ | 183364 | 5 |
View Market Depth
| Last trade - 16.10pm 12/11/2024 (20 minute delay) ? |
| SPL (ASX) Chart |